Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Management of Infected Wounds: A Wound Healing Foundation Consensus Statement.

Advances in wound care·2026

Same author

CD157<sup>+</sup> vascular endothelial stem cells represent a conserved subpopulation with an angiogenic gene expression profile.

Stem cell reports·2026

Same author

Transplantation of Ex Vivo Amplified Mononuclear Cells From Peripheral Blood Improves Rat Pulmonary Hypertension via CD14- and CD163-Positive M2 Macrophages.

Respirology (Carlton, Vic.)·2026

Same author

Logistical, Ethical, and Technical Considerations in the World's First Face and Whole Eye Transplantation.

Plastic and reconstructive surgery·2025

Same author

Analysis of Research Output by 2024 Matriculants to Top 30 Integrated Plastic Surgery Programs.

Annals of plastic surgery·2025

Same author

Uncontrolled Clinical Trial of Quality- and Quantity-Cultured Peripheral Blood Mononuclear Cell Therapy for Androgenetic Alopecia.

Plastic and reconstructive surgery·2025

Same journal

Pharyngeal Airway Changes Following Bimaxillary Orthognathic Surgery in Asian Patients.

The Journal of craniofacial surgery·2026

Same journal

Endoscopic Transcaruncular Approach for Early Anterior Ethmoidal Artery Cauterization in Large Olfactory Groove Meningioma Surgery: Intraoperative Video.

The Journal of craniofacial surgery·2026

Same journal

Clinical Manifestation of Congenital Unilateral Lower Lip Palsy: A Study of 111 Patients.

The Journal of craniofacial surgery·2026

Same journal

Racial and Regional Differences of the Cheek for Facial Feminization: A Systematic Review.

The Journal of craniofacial surgery·2026

Same journal

A Comparative Study Between the Modified Septal Extension Graft Based on the L-Strut Septum and the Costal Cartilage Graft Based on an Intact Native Septum in Nasal Plasty.

The Journal of craniofacial surgery·2026

Same journal

Does Angular Sagittal Split Osteotomy of the Mandibular Ramus Alter Fracture Patterns Compared With the Modifications of Posnick, Wolford, and Hunsuck/Epker?

The Journal of craniofacial surgery·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 19, 2026

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

Endogenous cell therapy improves bone healing.

John Layliev¹, Alexander Marchac, Rica Tanaka

¹From the *Department of Plastic Surgery, Institute of Reconstructive Plastic Surgery Laboratories, New York University Medical Center, New York, New York; and †Juntendo University School of Medicine, Department of Plastic and Reconstructive Surgery, Tokyo, Japan.

The Journal of Craniofacial Surgery

|December 16, 2014

Summary

This summary is machine-generated.

Combining AMD3100 to mobilize progenitor cells and recombinant human parathyroid hormone (rhPTH) to enhance their trafficking significantly improved bone healing in mouse cranial defects by boosting blood vessel formation.

More Related Videos

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Related Experiment Videos

Last Updated: Apr 19, 2026

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration

Published on: July 14, 2023

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

Area of Science:

Regenerative Medicine
Vascular Biology
Orthopedic Research

Background:

Bone defects often fail to heal due to inadequate blood supply.
Enhancing blood vessel formation is crucial for bone regeneration.
Targeting circulating progenitor cells (PCs) offers a potential therapeutic strategy.

Purpose of the Study:

To investigate if combining a progenitor cell-mobilizing agent (AMD3100) with a cell-trafficking enhancer (rhPTH) improves bone healing.
To assess the impact of combination therapy on progenitor cell numbers, vascularization, and bone regeneration in cranial defects.

Main Methods:

Critical-sized cranial defects were created in mice.
Mice received daily injections of AMD3100, rhPTH, both, or saline.
Circulating progenitor cell counts, new blood vessel formation, and bone regeneration were quantified.
In vitro assays assessed progenitor cell adhesion, migration, and tubule formation.

Main Results:

Combination therapy significantly increased circulating progenitor cells compared to controls.
AMD3100 enhanced progenitor cell adhesion and migration in vitro, particularly with rhPTH.
Combination therapy markedly improved new blood vessel formation and bone regeneration in cranial defects.

Conclusions:

The combined use of AMD3100 and rhPTH effectively promotes bone regeneration in calvarial defects.
This combination therapy enhances vasculogenesis and progenitor cell function for improved bone healing.